微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 88.39% | -5.36% | -5.02% | 4/159 | 31.52% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 93.06% | 0.67% | 0.1% | 6/159 | 51.8% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 92.96% | 0.61% | 0.25% | 5/159 | 22.98% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 92.73% | 0.25% | -0.71% | 7/159 | 33.39% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 93.4% | 0.34% | 1.03% | 6/159 | 51.73% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 92.44% | 1.2% | 0.05% | 6/159 | 51.53% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 92.4% | 0.94% | -0.11% | 5/159 | 32.76% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 92.5% | 0.55% | -0.62% | 5/159 | 38.65% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 93.08% | 0.88% | 1.89% | 4/159 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 91.35% | -5.54% | -0.21% | 7/159 | 53.74% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 91.54% | -4.83% | -0.49% | 6/159 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 91.99% | -3.33% | -0.29% | 5/159 | 21.74% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 92.26% | 2% | -4.6% | 5/159 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 96.71% | -3.2% | 0.54% | 3/159 | 55.21% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 96.19% | -3.77% | 1.07% | 2/159 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 95.17% | 2% | -4.74% | 3/159 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2020-12-31 | 99.9% | 2% | -0.06% | 2/159 | -144.37% | 艾力斯 | 99.4% | 行业排名> |
| 2020-09-30 | 99.96% | 2% | 2% | 1/159 | 56.57% | 首药控股 | 99.94% | 行业排名> |